Console Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 8.00 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.10 Cr
- Revenue Growth -20.47%
- Profit Growth -28.97%
- Ebitda 39.83%
- Net Worth 8.11%
- Total Assets 20.05%
About Console Lifesciences
Console Lifesciences Private Limited (CLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 July 2012 and has a history of 12 years and six months. Its registered office is in Patna, Bihar, India.
The Corporate was formerly known as Concept Life Science Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹4.10 Cr.
Amit Singh, Uma Shankar, and Vidya Sagar serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232BR2012PTC018971
-
Company No.
018971
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jul 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Console Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Shankar
|
Managing Director | 23-Jul-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Amit Singh
|
Director | 23-Jul-2012 | Current |
|
Vidya Sagar
|
Director | 23-Jul-2012 | Current |
Financial Performance of Console Lifesciences.
Console Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.47% decrease. The company also saw a substantial fall in profitability, with a 28.97% decrease in profit. The company's net worth moved up by a moderate rise of 8.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Console Lifesciences?
In 2021, Console Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Fantasy Drugs Private LimitedUma Shankar and Vidya Sagar are mutual person
Charges (Loans)
₹41.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 4.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2020 | Canara Bank | ₹6.00 M | Open |
| 23 Dec 2019 | Canara Bank | ₹5.00 M | Open |
| 30 Jan 2015 | Canara Bank | ₹3.00 Cr | Open |
How Many Employees Work at Console Lifesciences?
Unlock and access historical data on people associated with Console Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Console Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Console Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
